Adis JournalsBrowse
Summary slide.png (106.35 kB)
Download file

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects

Download (106.35 kB)
figure
posted on 08.04.2020, 14:43 authored by Martin Kankam, Rhonda Griffin, Jeffrey Price, Josée Michaud, Wei Liang, Mariona Bassas Llorens, Ana Sanz, Bradley Vince, David Vilardell

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

Usage metrics

Read the peer-reviewed publication

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
Advances in TherapyAdvances in Therapy

Categories

Keywords

EfficacyHepatitis A virusInfectious diseasesIntramuscular immunoglobulinPharmacokineticsSafetyTolerability

Licence

CC BY-NC 4.0

Exports